Clinical trial
Open-label Study of the Efficacy and Safety of VESIcare® in Patients With…
NCT00463541 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00463541 |
|---|---|
| Title | Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms |
| Official title | An Open-label Study of the Efficacy and Safety of 5 and 10mg VESIcare® (Solifenacin Succinate) in Patients With Overactive Bladder Symptoms VOLT: VESIcare® Open-Label Trial |
| Acronym | VOLT |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Bladder, Overactive |
| Intervention type | Drug |
| Interventions | solifenacin succinate |
| Enrollment | 2,225 |
| Start date | Jun 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Apr 20, 2007 |
| Last update posted | Sep 18, 2014 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: